{{Rsnum
|rsid=7624540
|Gene=GSK3B
|Chromosome=3
|position=119890100
|Orientation=plus
|GMAF=0.1942
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=GSK3B
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 3.5 | 38.9 | 57.5
| HCB | 0.0 | 12.4 | 87.6
| JPT | 0.0 | 11.5 | 88.5
| YRI | 12.9 | 41.5 | 45.6
| ASW | 8.9 | 46.4 | 44.6
| CHB | 0.0 | 12.4 | 87.6
| CHD | 0.9 | 13.9 | 85.2
| GIH | 4.0 | 38.6 | 57.4
| LWK | 10.9 | 50.9 | 38.2
| MEX | 1.7 | 25.9 | 72.4
| MKK | 1.9 | 37.8 | 60.3
| TSI | 2.9 | 45.1 | 52.0
| HapMapRevision=28
}}{{PMID|18500637}} [[rs7624540]], [[rs4072520]], [[rs6779828]] showed genotypic association with [[schizophrenia]]

{{PMID Auto
|PMID=20605420
|Title=Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians
}}

{{PMID|17270183|OA=1
}} Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}